This investigate was performed To judge the prospective in the CPPs with tumor-targeting Attributes to deliver a cytotoxic payload to HCC cells. We explored using a CXCR4-concentrating on peptide, T22, fused with cytotoxic peptide PE24, being a novel therapeutic technique for CXCR4+ HCC cells. T22 was chosen as the nanocarrier https://https-1433177-com40863.blogripley.com/32076767/the-definitive-guide-to-https-1433778-com